Fundraising Fox
🦊/People
Sign in

Jeffrey Finer

Investor

Venture Partner at Third Rock Ventures · Chief Executive Officer and Co-Founder at Septerna

West Coast

Writes $100K – $5M checks · typically $1.5M

Find your path to Jeffrey

454 people in our graph share verified history with Jeffrey — schools, employers, funds. One of them is your warm intro.

Mark SiegelunlockedJeffrey: together at Massachusetts Institute of Technology (1986–1988)
Jeffrey: together at Massachusetts Institute of Technology
×10Jeffrey: together at Third Rock Ventures

About

Jeffrey Finer is a physician-scientist who joined Third Rock Ventures as a Venture Partner in 2016, where he focuses on drug discovery and development opportunities across the firm's portfolio. He brings roughly 30 years of research and clinical experience, including 18 years leading drug discovery programs, preclinical development, and translational medicine efforts, and has moved several first-in-class drugs into the clinic. He has developed technology platforms integrating science, instruments, and informatics, holds several patents, and has published widely in peer-reviewed journals. He earned his M.D. and Ph.D. in Biochemistry from Stanford and B.S. degrees in Chemistry and Biology from MIT.

Beyond investing

Education
Holds B.S. degrees in Chemistry and Biology from the Massachusetts Institute of Technology. Earned his M.D. and Ph.D. in Biochemistry from Stanford University School of Medicine. Completed residency training in Internal Medicine at Stanford. Completed residency training in Ophthalmology at Massachusetts Eye & Ear Infirmary and Harvard Medical School.
Awards
Holds several patents and has published extensively in peer-reviewed journals.

Mentioned above: the Massachusetts Institute of Technology mafia → · the Stanford University School of Medicine mafia →

From Jeffrey's own website — common ground for a warm intro.

Chief Executive Officer and Co-Founder at Septerna

Intro paths

→

In turn, Jeffrey can intro founders to Septerna's investors below.

Septerna's investors · 5

Catalio Capital Management, LPNew York · since 2023RA CapitalBoston · since 2023Samsara BioCapitalPalo Alto · since 2023Third Rock VenturesBoston · $100K – $5M checks · since 2023Vertex Ventures HCSingapore · $500K – $10M checks · since 2023

Co-founders at Septerna

RL
Robert LefkowitzFounder
AC
Arthur ChristopoulosFounder
PS
Patrick SextonFounder

Experience

  1. SepternaCEO and Co-Foundercurrent2019 — presentSan Francisco Bay Area
  2. Third Rock VenturesVenture Partnercurrent2016 — presentSan Francisco Bay Area
  3. Maze TherapeuticsBoard Observer2019 — 2024
  4. Maze TherapeuticsInterim Chief Technology Officer2016 — 2019San Francisco Bay Area
  5. StrateosBoard Member2019 — 2024
  6. StrateosBoard Chairman2019 — 2022
  7. Ambys MedicinesBoard Observer2019 — 2022
  8. Ambys MedicinesInterim Chief Technology Officer2017 — 2019San Francisco Bay Area
  9. TranscripticBoard Member2018 — 2019
  10. Theravance Biopharma, Inc.Vice President, Research Technology2014 — 2016San Francisco Bay Area
  11. Theravance Biopharma, Inc.Vice President, Molecular & Cellular Biology2011 — 2014San Francisco Bay Area
  12. Five Prime TherapeuticsVice President, Discovery2007 — 2011San Francisco Bay Area
  13. CytokineticsDirector, Drug Discovery Technologies1998 — 2007San Francisco Bay Area
  14. Massachusetts Eye and EarResident Physician & Surgeon, Ophthalmology1996 — 1998
  15. Stanford University School of MedicineResident Physician, Internal Medicine1995 — 1996

Skills & more

Oncology13Assay Development9Lifesciences13Molecular Biology16Drug Discovery41Biomarker Discovery20Life Sciences15Pharmaceutical Industry17Biotechnology37Validation1Technology Transfer9Drug Development25
+8 moreBiochemistryCell CulturePharmacologyHPLCClinical DevelopmentCancerCROBiopharmaceuticals

From Jeffrey's professional profile.

Investments

Investor

Septerna

Per curated public sources.

Colleagues at Third Rock Ventures

Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alexis Borisy
General Partner at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures

Frequently asked questions

Who is Jeffrey Finer?
Jeffrey Finer is a physician-scientist who joined Third Rock Ventures as a Venture Partner in 2016, where he focuses on drug discovery and development opportunities across the firm's portfolio. He brings roughly 30 years of research and clinical experience, including 18 years leading drug discovery programs, preclinical development, and translational medicine efforts, and has moved several first-in-class drugs into the clinic. He has developed technology platforms integrating science, instruments, and informatics, holds several patents, and has published widely in peer-reviewed journals. He earned his M.D. and Ph.D. in Biochemistry from Stanford and B.S. degrees in Chemistry and Biology from MIT.
Where does Jeffrey Finer work?
Jeffrey Finer is Venture Partner at Third Rock Ventures and Chief Executive Officer and Co-Founder at Septerna.
What check size does Jeffrey Finer write?
Jeffrey Finer typically writes checks of $100K – $5M.
What companies has Jeffrey Finer invested in?
Investments tracked here include Septerna.
Where did Jeffrey Finer go to school?
Jeffrey Finer studied at Stanford University School of Medicine (MD PhD, Biophysics, Medicine); Massachusetts Institute of Technology (BS, Chemistry).
What awards has Jeffrey Finer received?
Holds several patents and has published extensively in peer-reviewed journals.

Founder mafias

Same school

Shared employers